Add time:07/21/2019         Source:sciencedirect.com

BackgroundPneumocystis jirovecii pneumonia (PCP) is an opportunistic infection in patients on steroid therapy for connective tissue diseases. The standard agent for primary PCP prophylaxis is trimethoprim/sulfamethoxazole (TMP-SMX), although this agent can cause common adverse reactions, including myelosuppression and renal toxicity, that result in cessation. Aerosolized pentamidine and oral atovaquone are alternatives for PCP prophylaxis. The efficacies of atovaquone, pentamidine, and TMP-SMX to prevent PCP in patients with connective tissue diseases have never been compared.

We also recommend Trading Suppliers and Manufacturers of Pentamidine (cas 100-33-4). Pls Click Website Link as below: cas 100-33-4 suppliers